Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrence Free Survival After Curative Resection of Non-small Cell Lung Cancer Between Inhalational Gas Anesthesia and Propofol-based Total IntraVenous Anesthesia: a Multicenter, Randomized, Clinical Trial

NCT06330038 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT06330038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06330038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrence Free Survival After Curative Resection of Non-small Cell Lung Cancer Between Inhalational Gas Anesthesia and Propofol-based Total IntraVenous Anesthesia: a Multicenter, Randomized, Clinical Trial
Lead sponsor
Samsung Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
August 5, 2024
Completion date
December 31, 2028
Enrollment
5,384 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, non-small cell lung cancer, surgery